Navigation Links
PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
Date:5/16/2013

SOUTH PLAINFIELD, N.J., May 16, 2013 /PRNewswire/ -- PTC Therapeutics, Inc., today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not been determined.

(Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO )

J.P. Morgan and Credit Suisse are acting as joint book-running managers for the offering. Cowen and Company is acting as co-lead manager and Wedbush PacGrow Life Sciences as co-manager.

A registration statement relating to these securities has been filed with the SEC, but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful, prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to the offering may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; telephone: 866-803-9204; or Credit Suisse Securities (USA) LLC, or Credit Suisse Prospectus Department, One Madison Avenue, New York, NY 10010; telephone: 1-800-221-1037; email: newyork.prospectus@credit-suisse.com.

About PTC Therapeutics, Inc.

PTC is a biopharmaceutical company focused on the discovery, development and potential commercialization of orally administered small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders, oncology and infectious diseases.


'/>"/>
SOURCE PTC Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
2. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
3. Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect
4. ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
5. Autoinjectors to 2018 - Devices, Therapeutics, Markets, Strategies and Prospects
6. ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"
7. Arno Therapeutics, Inc. Appoints Randy Thurman to the Board of Directors
8. Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
9. Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
10. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
11. Caliber and ImmunGene Launch Valor Biotherapeutics, a Joint Venture to Develop Antibody-Interferon Fusion Therapeutics to Treat Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2019)... ... October 22, 2019 , ... The American ... Advocacy Award for Excellence in a State Issue Campaign by the Professional Women ... and the contributions of ASDSA’s Advocacy team: Kristin Hellquist, Director of Advocacy and ...
(Date:10/22/2019)... ... 23, 2019 , ... A total of 27 Mercy ... issue, representing 22 separate specialties, ranging from breast surgery to pediatrics to gastroenterology. ... Dr. Rebecca Cerrato, Orthopedic Surgery: Foot & Ankle, Dr. Joseph Costa, Intensivists/Critical Care, ...
(Date:10/19/2019)... Calif. (PRWEB) , ... October 18, 2019 , ... ... the Organization of Teratology Information Specialists (OTIS) suggests adalimumab use in pregnancy was ... structural birth defects, spontaneous abortion and preterm delivery. The findings were ...
Breaking Medicine Technology:
(Date:10/8/2019)... VANCOUVER, British Columbia (PRWEB) , ... October 08, 2019 , ... ... about the current and future state of aging and wellness in the nation? That ... International Council on Active Aging Conference, Leadership Summit and Expo. The event will take ...
(Date:10/8/2019)... ... October 08, 2019 , ... In Vitro ... in Advanced Fertility Care (AFC), an advanced reproductive services (RE) facility operating in ... availability of RE services to expectant families throughout Arizona and the greater Southwest. ...
(Date:10/8/2019)... ... October 08, 2019 , ... Cognosante has been awarded a ... Affairs Community Care Referrals and Authorizations program. The new task order will allow ... Manager (HSRM), an enterprise-wide system used by community care staff to generate referrals ...
(Date:10/8/2019)... ... October 08, 2019 , ... As a world-renowned ... Shi, associate professor with the University of Maryland Department of Veterinary Medicine, continues ... Nature Communications, Shi and his lab have discovered a new pathway by which ...
(Date:10/8/2019)... ... 2019 , ... Over the past three decades, Buffalo Wings & Rings has ... category by providing a higher-quality product and experience than the competition. Now, the club-level ... "RAISE A MUG FOR THE CAUSE" campaign in support of Breast Cancer Awareness Month. ...
Breaking Medicine News(10 mins):